Clinical Trial Update: Study MIPAE - Melatonin and Essential Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update for MIPAE evaluating melatonin in essential hypertension; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Essential Hypertension | Phase 2 | Status: UNKNOWN